We've seen quite a long, and somewhat, complex bull market over the past few years, writes Tom Bradley, of The Globe and Mail, who analyzes it through a three-pronged approach.
A long stock market run goes through many phases. There's a healthy debate going on right now as to where this one is at��oes it have further to go, or is it over? In assessing where we are, it's useful to look back at how things unfolded over the last four and a half years, and understand why markets have gone up so much.
I'm going to look at it through three lenses��undamentals (the outlook for profits and dividends); valuation (what we're paying for those profits and dividends) and investor sentiment (how bullish or bearish investors are).
When this bull market started on March 9, 2009, the fundamentals didn't look very good. The banks were teetering, a recession was imminent, and the outlook for earnings was poor, to say the least.
In hindsight, it was as good a starting point for a bull market as you'll ever see. The necessary requirements were all there�� poor short-term outlook, rock-bottom price to earnings multiples (P/Es), forced selling from margin accounts and liquidity-strained pensions funds, and a feeling that we'll never make a decent return in the stock market again.
Hot Prefered Stocks To Buy For 2016: Tanger Factory Outlet Centers Inc.(SKT)
Tanger Factory Outlet Centers, Inc. operates as a real estate investment trust (REIT). The company, through its subsidiary, Tanger Properties Limited Partnership, engages in acquiring, developing, owning, operating, and managing factory outlet shopping centers. As of September 30, 2005, Tanger owned and operated 33 factory outlet centers in 22 states totaling 8.7 million square feet of gross leasable area. It also provides development, leasing, and management services for its outlet centers. The company has elected to be taxed as a REIT under the Internal Revenue Code. As a REIT, it would not be subject to Federal income taxes provided it distributes at least 90% of its taxable income to its shareholders. Tanger Factory Outlet Centers was founded by Stanley K. Tanger in 1981. The company is headquartered in Greensboro, North Carolina.
Advisors' Opinion:- [By U.S. News]
Linda Davidson/The Washington Post via Getty ImagesShoppers at the Tanger Outlet Mall in Oxon Hill, Md. There are few forms of shopping I enjoy more than outlet shopping. There is something about all of those discount stores packed so closely together that makes me super excited! But I am not going to tell you that all outlet stores are a good deal, because some of them are not. Also, brands sometimes create cheaper items to sell specifically in their outlet locations, and those are not always a smart buy. But for the most part, outlet malls are still an excellent way to save some money while picking up items for the entire family. Here are five ways to make the most of your trip to an outlet: 1. Figure out the outlet 'brand.' There are a couple of management companies that own quite a few outlet malls in the United States, including Premium Outlets (SPG) and Tanger Factory Outlet Centers (SKT). Before heading out, be sure to check the website for the entire outlet mall for any possible deals or coupons. Premium and Tanger Outlets also have Facebook (FB) pages where they will occasionally post coupons that you can print from home. 2. Look for an outlet discount card or VIP program. Many outlet malls have VIP savings programs that can save you big bucks throughout the year and also give you special access to new promotions and sales. The Fashion Outlets of Chicago opened last year and offer a Green Savings Card that costs $5 for a yearly membership. Those with a Green Savings Card receive extra discounts at a huge number of stores and restaurants in the mall, which is on top of the already low prices. 3. 'Like' the outlet store on Facebook. If there is an outlet store that you frequent, go ahead and like its Facebook page so that you will be one of the first to know about sales and promotions. The Kate Spade Outlet (KATE) will frequently post promotions to Facebook before emailing subscribers. The J. Crew Factory Store has offered special promotions th
- [By Marc Bastow]
Discount outlet shopping-center retailer Tanger (SKT) raised its quarterly dividend� 6.7% to 24 cents per share payable on May 15 to shareholders of record April 28. The increase is the 21st consecutive dividend increase for SKT.
SKT Dividend Yield: 2.71%
Top Integrated Utility Stocks To Own For 2015: Boston Therapeutics Inc (BTHE)
Boston Therapeutics, Inc. is a development-stage company. The Company�� business is the development, manufacture and commercialization of therapeutic drugs and dietary supplements with a focus on glyco-pathology, a specialized field involving understanding the importance of carbohydrates in biochemistry and progression of diseases. The Company is focusing on three products: IPOXYN, an injectable anti-hypoxia drug, which it is developing; PAZ320, which is a non-systemic, chewable drug candidate for reduction of blood glucose in diabetics in development and SUGARDOWN, a complex carbohydrate-based chewable dietary supplement, which it is marketing. The Company�� non-systemic compounds for prediabetes and diabetes, SUGARDOWN and PAZ320, belong to the class of carbohydrate-hydrolyzing enzyme inhibitors.
SUGARDOWN
The Company has developed SUGARDOWN, a non-systemic complex carbohydrate-based dietary supplement to moderate post-meal blood glucose using processes and technology. It has unrestricted access to both sufficient raw materials at commodity pricing and processing facilities to produce sufficient supply of SUGARDOWN to support product distribution across multiple sales channels as a dietary supplement. Its SUGARDOWN dietary supplement consists of a stabilized complex carbohydrate composition. The Company has completed development of SUGARDOWN as a dietary supplement. On January 24, 2012 the Company announced the clinical trial results in healthy volunteers performed at the University of Sydney on SUGARDOWN.
PAZ320
PAZ320 is a non-systemic, non-toxic, chewable drug candidate for prevention of diabetes and its complications. PAZ320 inhibits the enzymes, which release glucose from complex carbohydrate in foods during digestion, reducing the amount of available glucose absorbed through the intestine. PAZ320 is in development as a drug candidate. The Company�� non-systemic compounds for prediabetes and diabetes, SUGARDOWN and PAZ320, belong to the! class of carbohydrate-hydrolyzing enzyme inhibitors.
IPOXYN
The Company has developed a drug candidate product IPOXYN, a glyco-protein based therapeutic agent. Its IPOXYN anti-hypoxia drug consists of a stabilized glycoprotein composition containing oxygen-rechargeable iron, targeting both human and animal tissues and organ systems deprived of oxygen and in need of metabolic support. In addition to potential uses for human patients, it also focuses to file a registration for IPOXYN for veterinary applications under the name OXYFEX. The Company�� pharmaceutical agents are intended for intravenous administration into the circulatory system to target acute and late stage diseases.
Advisors' Opinion:- [By CRWE]
Today, BTHE remains (0.00%) +0.000 at $1.10 thus far (ref. google finance Delayed: 12:25PM EDT October 10, 2013).
Boston Therapeutics has previously closed the final tranche of approximately $1.8 million to bring total gross proceeds of approximately $5.3 million from the private placement of Common Stock and warrants to existing and new accredited investors (the “Offering”).
Proceeds of the offering will be used to fund additional clinical trials for PAZ320, a non-systemic chewable drug designed to reduce the elevation of postprandial glucose or post-meal blood sugar for treatment of patients with Type 2 diabetes, and for general corporate purposes. PAZ320 is the first compound in a new class of therapies for this disease.
Top Integrated Utility Stocks To Own For 2015: US Ecology Inc.(ECOL)
US Ecology, Inc., through its subsidiaries, provides waste treatment, disposal, recycling, and transportation services to commercial and government entities in the United States. The company offers treatment and disposal services for radioactive, hazardous, polychlorinated biphenyl, and non-hazardous industrial wastes. Its customers include oil refineries, chemical production facilities, manufacturers, electric utilities, steel mills, biotechnology companies, military installations, waste brokers/aggregators, and medical and academic institutions. The company was formerly known as American Ecology Corporation and changed its name to US Ecology, Inc. in February 2010. US Ecology, Inc. was founded in 1952 and is headquartered in Boise, Idaho.
Advisors' Opinion:- [By Lauren Pollock]
Among the stocks to watch in Monday’s session are US Ecology Inc.(ECOL), Akamai, and Dow Chemical Co.(DOW)
US Ecology again raised its earnings guidance for the year, pointing to strong volumes and accelerated project shipments, but warned its results for next year may take a hit as a result. The company, which provides waste- management and recycling services, also outlined plans to offer about $100 million in stock. Shares dropped 10% to $34.51 premarket.
- [By Damian Illia]
As we can see, the firm has a higher ROE than Amrep Corporation (AXR) but is well below the one registered by US Ecology Inc. (ECOL) and Cintas Corporation (CTAS).
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, hazardous waste disposal specialist US Ecology (NASDAQ: ECOL ) has earned a coveted five-star ranking.
Top Integrated Utility Stocks To Own For 2015: MWI Veterinary Supply Inc.(MWIV)
MWI Veterinary Supply, Inc., together with its subsidiaries, engages in the distribution of animal health products to veterinarians in the United States and the United Kingdom. It primarily offers pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, supplies, specialty products, veterinary pet food, and nutritional products. The company?s pharmaceutical products include anesthetics, analgesics, antibiotics, ophthalmics, and hormones; vaccine products consist of small animal, equine, and production animal biologicals; and parasiticides are used for control of fleas, ticks, flies, mosquitoes, and internal parasites. Its diagnostics products comprise consumable in-clinic tests for detecting heartworm, lyme, feline leukemia, and parvovirus, as well as consumable products for measuring blood chemistry, electrolyte balance, and cell counts; capital equipment products include anesthesia machines, surgical monitors, diagnostic equipment, dental machines, cage s, lights, and x-ray machines; and supplies consists of syringes, instruments, bandages, IV products, surgical consumables, grooming materials, and other small equipment items. The company?s veterinary pet foods products include foods for specialty diets and premium pet foods; and nutritional products comprise dietary supplements, vitamins, dental chews, and specialty treats. As of September 30, 2011, it served approximately 24,000 veterinary practices in the United States; and 1,500 veterinary practices in the United Kingdom. The company was formerly known as MWI Holdings, Inc. and changed its name to MWI Veterinary Supply, Inc. in April 2005. MWI Veterinary Supply, Inc. was founded in 1976 and is headquartered in Boise, Idaho.
Advisors' Opinion:- [By Sean Williams]
Bursting with paw-tential
No stock goes straight up, but between 2009 and 2014 it was a steep uphill ride for stakeholders in animal health products company�MWI Veterinary Supply (NASDAQ: MWIV ) , who saw their shares rise in value by more than 700%. But all good things must end, and shares of the company have dipped by more than 20% from their all-time high set earlier this year. - [By Rupert Hargreaves]
Pet-related companies are highly sought after
Having said that, it would appear that in comparison to the rest of the pet-related sector, Zoetis is fairly valued. Peer MWI Veterinary Supply (NASDAQ: MWIV ) trades at 27 times forward earnings, and again the company is highly defensive, engaging in the distribution of animal health products to veterinarians in the United States and the United Kingdom. Veterinary supply is exposed to the same demand factors as Zoetis -- greater demand for animal treatments will lead to more demand for the distribution of animal health products. - [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on MWI Veterinary Supply (Nasdaq: MWIV ) , whose recent revenue and earnings are plotted below.
No comments:
Post a Comment